meciadanol has been researched along with Gastric Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganote, DP; Hennings, G; Lücker, PW | 1 |
1 other study(ies) available for meciadanol and Gastric Diseases
| Article | Year |
|---|---|
3-Methoxy-5,7,3',4'-tetrahydroxyflavan (ME): a new compound to prevent gastric irritation. A gastric potential difference analysis.
Topics: Aspirin; Catechin; Dose-Response Relationship, Drug; Flavonoids; Gastric Mucosa; Humans; Irritants; Male; Membrane Potentials; Random Allocation; Stomach Diseases | 1983 |